| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Mitalee Tamhane | Q91182728 |
| P2093 | author name string | Veena Viswanath | |
| Grigor Abelian | |||
| Sara Cabrera-Ghayouri | |||
| P2860 | cites work | Histamine H1 and H4 receptor expression on the ocular surface of patients with chronic allergic conjunctival diseases. | Q50740021 |
| The analysis of human conjunctival epithelium proteome in ocular surface diseases using impression cytology and 2D-DIGE. | Q51089122 | ||
| Relationships between vitreous levels of soluble receptor for advanced glycation end products (sRAGE) and renal function in patients with diabetic retinopathy. | Q51335095 | ||
| Detection of IFN-γ+IL-17+ cells in salivary glands of patients with Sjögren's syndrome and Mikulicz's disease: Potential role of Th17•Th1 in the pathogenesis of autoimmune diseases. | Q51354997 | ||
| Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. | Q51549282 | ||
| In Vivo Scanning Laser Confocal Microscopy of Conjunctival Goblet Cells in Medically-controlled Glaucoma. | Q51748290 | ||
| Protein composition of human aqueous humor: SDS-PAGE analysis of surgical and post-mortem samples. | Q51758042 | ||
| Aqueous humor protein dysregulation in primary angle-closure glaucoma. | Q52656791 | ||
| Vitreous levels of proteins implicated in angiogenesis are modulated in patients with retinal or choroidal neovascularization. | Q52887319 | ||
| Randomized Controlled Crossover Trial Comparing the Impact of Sham or Intranasal Tear Neurostimulation on Conjunctival Goblet Cell Degranulation. | Q52889830 | ||
| Tear proteomic analysis of patients with type 2 diabetes and dry eye syndrome by two-dimensional nano-liquid chromatography coupled with tandem mass spectrometry. | Q53099214 | ||
| Expression of Lipid Peroxidation Markers in the Tear Film and Ocular Surface of Patients with Non-Sjogren Syndrome: Potential Biomarkers for Dry Eye Disease. | Q53177612 | ||
| Differential cell proliferation, apoptosis, and immune response in healthy and evaporative-type dry eye conjunctival epithelia. | Q53255424 | ||
| A Simple Spontaneous Vitreal Reflux Collecting Procedure During Intravitreal Injection: Set-Up and Validation Studies. | Q53310348 | ||
| Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. | Q53572321 | ||
| Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. | Q53891879 | ||
| Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome | Q21133793 | ||
| Disease-related quantitation of TGF-beta3 in human aqueous humor | Q24301921 | ||
| iTRAQ quantitative proteomics in the analysis of tears in dry eye patients | Q24624997 | ||
| Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine | Q26740411 | ||
| Biomarkers and surrogate endpoints: preferred definitions and conceptual framework | Q28203935 | ||
| PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity | Q28241023 | ||
| Mass spectrometry-based proteomic analyses in contact lens-related dry eye | Q28259300 | ||
| Autotaxin-lysophosphatidic acid axis is a novel molecular target for lowering intraocular pressure | Q28482420 | ||
| Proteomic Analysis of Vitreous Humor in Retinal Vein Occlusion | Q28552292 | ||
| Vitreous and serum levels of vascular endothelial growth factor and platelet-derived growth factor and their correlation in patients with non-proliferative diabetic retinopathy and clinically significant macula oedema. | Q30874452 | ||
| SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. | Q31149662 | ||
| Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging | Q31170436 | ||
| Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. | Q31775977 | ||
| Identification and localization of major soluble vitreous proteins in human ocular tissue | Q33200770 | ||
| Analysis of Th17-associated cytokines in tears of patients with dry eye syndrome | Q33595169 | ||
| Proteome alterations in primary open angle glaucoma aqueous humor. | Q33643384 | ||
| Profiles of extracellular miRNAs in the aqueous humor of glaucoma patients assessed with a microarray system | Q33671943 | ||
| Association of preoperative vitreous IL-8 and VEGF levels with visual acuity after vitrectomy in proliferative diabetic retinopathy | Q33745645 | ||
| Goblet Cells Contribute to Ocular Surface Immune Tolerance-Implications for Dry Eye Disease. | Q33755012 | ||
| The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research | Q33756582 | ||
| Regulation of intercellular adhesion molecule-1 (CD54) gene expression | Q33805930 | ||
| Tear cathepsin S as a candidate biomarker for Sjögren's syndrome | Q33831656 | ||
| Association between high tear epidermal growth factor levels and corneal subepithelial fibrosis in dry eye conditions | Q33845310 | ||
| HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease | Q33861286 | ||
| Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease | Q33869200 | ||
| Lacrimal gland-derived IL-22 regulates IL-17-mediated ocular mucosal inflammation | Q33870377 | ||
| Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatory mediators in the eyelid margin and conjunctiva of patients with meibomian gland disease | Q33870384 | ||
| Structural macromolecules and supramolecular organisation of the vitreous gel. | Q33882468 | ||
| Myocilin levels in primary open-angle glaucoma and pseudoexfoliation glaucoma human aqueous humor | Q33938138 | ||
| Proteomics analysis of human tears from aqueous-deficient and evaporative dry eye patients | Q37110777 | ||
| Interleukin-1β and tumour necrosis factor-α levels in conjunctiva of diabetic patients with symptomatic moderate dry eye: case-control study | Q37177382 | ||
| Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations | Q37276376 | ||
| Impression cytology: recent advances and applications in dry eye disease. | Q37453774 | ||
| Dataset of tear film cytokine levels in dry eye disease (DED) patients with and without HIV infection | Q37472797 | ||
| Biomarkers in clinical drug development | Q37523221 | ||
| In vivo confocal microscopy of the ocular surface: from bench to bedside | Q37649719 | ||
| The Human Eye Proteome Project: perspectives on an emerging proteome | Q37689580 | ||
| Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease | Q37721598 | ||
| Proteomics in ocular fluids | Q37817122 | ||
| The role of TGF-β in the pathogenesis of primary open-angle glaucoma. | Q37958629 | ||
| Tear analysis in ocular surface diseases | Q38021534 | ||
| A brief history of anti-VEGF for the treatment of ocular angiogenesis | Q38022991 | ||
| Molecular and cellular biomarkers in dry eye disease and ocular allergy. | Q38034859 | ||
| Tears as a source of biomarkers for ocular and systemic diseases | Q38123623 | ||
| Allergy and allergic mediators in tears | Q38124638 | ||
| Tear fluid biomarker profiling: a review of multiplex bead analysis | Q38151225 | ||
| Vitreous biomarkers in diabetic retinopathy: a systematic review and meta-analysis | Q38196079 | ||
| Mucins: a biologically relevant glycan barrier in mucosal protection | Q38211343 | ||
| Nitric oxide (NO): an emerging target for the treatment of glaucoma | Q38240119 | ||
| Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases. | Q38285522 | ||
| Identification of Potential Biomarkers for Rhegmatogenous Retinal Detachment Associated with Choroidal Detachment by Vitreous iTRAQ-Based Proteomic Profiling | Q38439291 | ||
| Proteomics of human aqueous humor. | Q38463674 | ||
| Altered Mucin and Glycoprotein Expression in Dry Eye Disease | Q38565387 | ||
| Neuroinflammation in Glaucoma and Optic Nerve Damage | Q38574387 | ||
| Angiogenic and Inflammatory Vitreous Biomarkers Associated With Increasing Levels of Retinal Ischemia | Q38602347 | ||
| TFOS DEWS II Tear Film Report. | Q38652990 | ||
| Unconventional aqueous humor outflow: A review | Q38724447 | ||
| Goblet cells of the conjunctiva: A review of recent findings | Q38811416 | ||
| Immunological impression cytology of the conjunctival epithelium in patients with thyroid orbitopathy-related dry eye. | Q38814602 | ||
| The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders. | Q38817664 | ||
| Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice. | Q38835672 | ||
| Emerging therapeutics for ocular surface disease | Q38943854 | ||
| The Intriguing Role of Neuropeptides at the Ocular Surface | Q39007110 | ||
| Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye. | Q39030112 | ||
| Effects of Punctal Occlusion on Clinical Signs and Symptoms and on Tear Cytokine Levels in Patients with Dry Eye. | Q39177989 | ||
| Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy | Q39260919 | ||
| Association of NT-proANP Level in Plasma and Humor Aqueous with Primary Open-Angle Glaucoma | Q39306083 | ||
| Regulation of elastin promoter by lysyl oxidase and growth factors: cross control of lysyl oxidase on TGF-beta1 effects | Q40152221 | ||
| Level of Vascular Endothelial Growth Factor in the Vitreous Fluid of Proliferative Diabetic Retinopathy Patients and Prognosis after Vitrectomy | Q40506185 | ||
| Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome | Q40660004 | ||
| The role of conjunctival epithelial cells in chronic ocular allergic disease | Q40829833 | ||
| Clinical Usefulness of Monitoring Expression Levels of CCL24 (Eotaxin-2) mRNA on the Ocular Surface in Patients with Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis | Q41266829 | ||
| Surrogate endpoints in clinical trials: definition and operational criteria | Q41310696 | ||
| Basic physiology of the drainage of aqueous humor | Q41348458 | ||
| Interaction of IFN-γ with cholinergic agonists to modulate rat and human goblet cell function. | Q41386825 | ||
| Metabolomic analysis of human vitreous humor differentiates ocular inflammatory disease. | Q41437955 | ||
| Nitric oxide in the eye: multifaceted roles and diverse outcomes | Q41572716 | ||
| Safety and Feasibility of Quantitative Multiplexed Cytokine Analysis From Office-Based Vitreous Aspiration. | Q41891788 | ||
| Transforming growth factor-beta levels in human aqueous humor of glaucomatous, diabetic and uveitic eyes | Q41911194 | ||
| Changes of lacrimal gland and tear inflammatory cytokines in thyroid-associated ophthalmopathy | Q42461690 | ||
| Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease | Q42496546 | ||
| Elevated glucose attenuates agonist- and flow-stimulated endothelial nitric oxide synthase activity in microvascular retinal endothelial cells | Q42509735 | ||
| Elevated levels of multiple biomarkers of Alzheimer's disease in the aqueous humor of eyes with open-angle glaucoma | Q42609277 | ||
| Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development | Q42652061 | ||
| Correlation of pseudoexfoliative material and optic nerve damage in pseudoexfoliation syndrome | Q42667961 | ||
| Multiplex immunoassay analysis of biomarkers in clinically accessible quantities of human aqueous humor. | Q43202385 | ||
| Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy. | Q43244563 | ||
| Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease | Q43723395 | ||
| Aqueous humor in primary open-angle glaucoma contains an increased level of CD44S. | Q43843361 | ||
| Significant variation of the elevated nitric oxide levels in aqueous humor from patients with different types of glaucoma | Q44211222 | ||
| Structural differences in the structure of the ciliary muscles in eyes of primates. A histochemical and morphological study | Q44248979 | ||
| Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease. | Q44536720 | ||
| Oxidative stress markers in aqueous humor of glaucoma patients | Q44710317 | ||
| Ocular mucin gene expression levels as biomarkers for the diagnosis of dry eye syndrome. | Q44757521 | ||
| Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive Model. | Q44820020 | ||
| Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease | Q45229126 | ||
| Hyperosmolar stress upregulates HLA-DR expression in human conjunctival epithelium in dry eye patients and in vitro models | Q45269167 | ||
| Correlation between Interleukin-6 and Thrombin-Antithrombin III Complex Levels in Retinal Diseases | Q45869007 | ||
| [The expression of vascular endothelial growth factor of vitreous in patients with proliferative diabetic retinopathy]. | Q45941002 | ||
| A prospective study of in-office diagnostic vitreous sampling in patients with vitreoretinal pathology | Q46047800 | ||
| Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions. | Q46080871 | ||
| Gene Expression-Based Predictive Models of Graft Versus Host Disease-Associated Dry Eye. | Q46136286 | ||
| Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy | Q46171948 | ||
| Components of the fibrinolytic system in the vitreous body in patients with vitreoretinal disorders | Q46306576 | ||
| Analysis of the correlations of mucins, inflammatory markers, and clinical tests in dry eye. | Q46716997 | ||
| Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease | Q46831270 | ||
| Adaptation of impression cytology to enable conjunctival surface cell transcriptome analysis | Q46834579 | ||
| Proteomics of vitreous in neovascular age-related macular degeneration | Q46870123 | ||
| Upregulation of ICAM-1 expression in the conjunctiva of patients with chronic graft-versus-host disease | Q46958984 | ||
| Tear proteome analysis in ocular surface diseases using label-free LC-MS/MS and multiplexed-microarray biomarker validation | Q47112214 | ||
| Link between neurodegeneration and trabecular meshwork injury in glaucomatous patients | Q47144462 | ||
| A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema | Q47230436 | ||
| Natural Immunity and Ocular Inflammation | Q47308738 | ||
| Biomarkers of ocular surface disease using impression cytology | Q47357127 | ||
| Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay | Q47374338 | ||
| RNA Collection From Human Conjunctival Epithelial Cells Obtained With a New Device for Impression Cytology | Q47397638 | ||
| Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy | Q47424741 | ||
| Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma | Q34005664 | ||
| Human tear lipocalin | Q34073693 | ||
| Aqueous humor dynamics: a review | Q34162577 | ||
| Abnormal protein profiles in tears with dry eye syndrome | Q34218114 | ||
| New proteins as vascular biomarkers in primary open angle glaucomatous aqueous humor. | Q34278577 | ||
| Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders | Q34292807 | ||
| Vitreous and plasma VEGF levels as predictive factors in the progression of proliferative diabetic retinopathy after vitrectomy | Q34352379 | ||
| Establishing PAX6 as a biomarker to detect early loss of ocular phenotype in human patients with Sjögren's syndrome | Q34473772 | ||
| Tear proteome and protein network analyses reveal a novel pentamarker panel for tear film characterization in dry eye and meibomian gland dysfunction | Q34497227 | ||
| Alterations in the tear proteome of dry eye patients--a matter of the clinical phenotype | Q34593416 | ||
| Significance of mucin on the ocular surface | Q34627790 | ||
| Proteome analysis of human aqueous humor | Q34735417 | ||
| Effects of prostaglandins on the aqueous humor outflow pathways | Q34805026 | ||
| Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis | Q34824549 | ||
| A method to extract cytokines and matrix metalloproteinases from Schirmer strips and analyze using Luminex | Q34912766 | ||
| Tumor necrosis factor-alpha (TNF-α) levels in aqueous humor of primary open angle glaucoma | Q34987608 | ||
| Anatomy and pathology of the vitreo-retinal interface. | Q35188973 | ||
| The chemical morphology of the vitreous | Q35188978 | ||
| Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy. | Q35189187 | ||
| Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease | Q35197785 | ||
| Brain natriuretic peptide: identification of a second natriuretic peptide in human aqueous humour | Q35305923 | ||
| Surrogate endpoints: a basis for a rational approach | Q35488355 | ||
| Alteration of galectin-3 in tears of patients with dry eye disease | Q35589468 | ||
| Human preocular mucins reflect changes in surface physiology | Q35591816 | ||
| Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma | Q35592096 | ||
| Role of mucins in the function of the corneal and conjunctival epithelia | Q35624244 | ||
| Aqueous humor TGF-β2 levels in patients with open-angle glaucoma: A meta-analysis. | Q35651380 | ||
| Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome | Q35674608 | ||
| Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease | Q35732401 | ||
| Variability of Tear Osmolarity in Patients With Dry Eye. | Q35738567 | ||
| Distribution of mucins at the ocular surface | Q35755130 | ||
| Functional dichotomy: glutathione and vitamin E in homeostasis relevant to primary open-angle glaucoma | Q35795259 | ||
| Modulation of HLA-DR in dry eye patients following 30 days of treatment with a lubricant eyedrop solution | Q35799409 | ||
| Induction of resistance to endothelin-1's biochemical actions by elevated glucose levels in retinal pericytes | Q54256762 | ||
| Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. | Q54301170 | ||
| Vascular endothelial growth factor and its soluble receptors-1 and -2 in iris neovascularization and neovascular glaucoma. | Q54343860 | ||
| Analysis of inflammatory cytokines in the tears of dry eye patients. | Q54467014 | ||
| Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis. | Q54568510 | ||
| Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. | Q54596780 | ||
| Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. | Q54602794 | ||
| Proinflammatory Markers, Chemokines, and Enkephalin in Patients Suffering from Dry Eye Disease. | Q54943596 | ||
| Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment. | Q55007680 | ||
| Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy. | Q55512926 | ||
| Differential profiling of lacrimal cytokines in patients suffering from thyroid-associated orbitopathy. | Q55717336 | ||
| Association of tear proteins with Meibomian gland disease and dry eye symptoms | Q56775803 | ||
| Identification of Tear Fluid Biomarkers in Dry Eye Syndrome Using iTRAQ Quantitative Proteomics | Q56775850 | ||
| Homocysteine levels in aqueous humor and plasma of patients with primary open-angle glaucoma | Q57780594 | ||
| Conjunctival Epithelium Expression of HLA-DR in Dry Eye Patients | Q58205031 | ||
| Inflammatory Markers in the Tears of Patients with Ocular Surface Disease | Q58979336 | ||
| Alterations of Tear Neuromediators in Dry Eye Disease | Q61196350 | ||
| Metabolomics Analysis of Human Vitreous in Diabetic Retinopathy and Rhegmatogenous Retinal Detachment | Q61782611 | ||
| Effects of Sequential Artificial Tear and Cyclosporine Emulsion Therapy on Conjunctival Goblet Cell Density and Transforming Growth Factor-β2 Production | Q61851319 | ||
| Cytokine and chemokine levels in tears from healthy subjects | Q62075176 | ||
| Intra- and inter-day variation of cytokines and chemokines in tears of healthy subjects | Q62116714 | ||
| Conjunctival Mucin mRNA Expression in Contact Lens Wear | Q62116743 | ||
| Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients | Q62398516 | ||
| Efficacy of polyethylene glycol-propylene glycol-based lubricant eye drops in reducing squamous metaplasia in patients with dry eye disease. | Q64882895 | ||
| Aqueous humor dynamics in monkeys (Macaca irus and Cercopithecus ethiops) | Q67236446 | ||
| Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation | Q67684445 | ||
| Protein levels in nonstimulated and stimulated tears of normal human subjects | Q68818873 | ||
| Tear protein composition and the effects of stimulus | Q72058967 | ||
| Sjögren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium | Q72120476 | ||
| Rapid assay of lactoferrin in keratoconjunctivitis sicca | Q72504994 | ||
| Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca | Q72993423 | ||
| Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis | Q73293753 | ||
| Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation | Q73434690 | ||
| Brush technique in ocular surface cytology | Q73590440 | ||
| TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells | Q73900323 | ||
| Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion | Q74120740 | ||
| Hepatocyte growth factor is increased in the aqueous humor of glaucomatous eyes | Q74151203 | ||
| Effects of ascorbic acid on levels of fibronectin, laminin and collagen type 1 in bovine trabecular meshwork in organ culture | Q74382421 | ||
| Aqueous humor dynamics in the aging human eye | Q77370299 | ||
| The pathology of dry eye: the interaction between the ocular surface and lacrimal glands | Q77575256 | ||
| Alteration of mucin in human conjunctival epithelia in dry eye | Q77695600 | ||
| Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine | Q77729873 | ||
| Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome | Q77846439 | ||
| Decreased nitric oxide production in primary open-angle glaucoma | Q77889861 | ||
| Evaluation of point-of-care test for elevated tear matrix metalloproteinase 9 in post-LASIK dry eyes. | Q35872889 | ||
| Human conjunctival goblet cells express the membrane associated mucin MUC16: Localization to mucin granules | Q35885777 | ||
| Biomarkers and surrogate endpoints in glaucoma clinical trials | Q35912696 | ||
| Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology | Q35925826 | ||
| Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype | Q35935203 | ||
| MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD. | Q35970512 | ||
| MicroRNA Profiling in Aqueous Humor of Individual Human Eyes by Next-Generation Sequencing. | Q35985547 | ||
| Biomarkers and surrogate markers: an FDA perspective | Q36045270 | ||
| Inflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival Cells | Q36074078 | ||
| Comparing Optic Nerve Head Rim Width, Rim Area, and Peripapillary Retinal Nerve Fiber Layer Thickness to Axon Count in Experimental Glaucoma | Q36074874 | ||
| Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis | Q36209773 | ||
| An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications | Q36279711 | ||
| Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease | Q36335761 | ||
| Aqueous Tear Deficiency Increases Conjunctival Interferon-γ (IFN-γ) Expression and Goblet Cell Loss | Q36345503 | ||
| The role of oxidative stress in glaucoma | Q36368431 | ||
| Investigation of the human tear film proteome using multiple proteomic approaches | Q36499336 | ||
| Molecular biomarkers in glaucoma | Q36530573 | ||
| Tear cytokine profiles in dysfunctional tear syndrome. | Q36637791 | ||
| Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome | Q36676823 | ||
| Comparison of low-abundance biomarker levels in capillary-collected nonstimulated tears and washout tears of aqueous-deficient and normal patients | Q36890904 | ||
| Two Patients with Dry Eye Disease Followed Up Using an Expression Assay of Ocular Surface Mucin | Q36906345 | ||
| Diagnostic performance of a tear protein panel in early dry eye | Q36908864 | ||
| Interferon-γ-Induced Unfolded Protein Response in Conjunctival Goblet Cells as a Cause of Mucin Deficiency in Sjögren Syndrome | Q36990222 | ||
| Introduction to metabolomics and its applications in ophthalmology. | Q37000717 | ||
| Conjunctival HLA-DR and CD8 expression detected by impression cytology in ocular graft versus host disease | Q37027349 | ||
| A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease | Q37038747 | ||
| Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression | Q37071969 | ||
| Increased malondialdehyde concentration and reduced total antioxidant capacity in aqueous humor and blood samples from patients with glaucoma | Q37091567 | ||
| Calcium-binding S100 protein expression in pterygium | Q37097531 | ||
| Multiple cytokine analysis in human tears: an optimized procedure for cytometric bead-based assay | Q47594873 | ||
| Inflammatory cytokines in normal human tears | Q47847615 | ||
| Concentration of acute phase factors in vitreous fluid in diabetic macular edema | Q48014506 | ||
| Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome | Q48244820 | ||
| Blood circulation and fluid dynamics in the eye | Q48452183 | ||
| Quantification of MUC5AC protein in human tears. | Q48520717 | ||
| Identification and Characterization of Circular RNAs as a New Class of Putative Biomarkers in Diabetes Retinopathy. | Q49485089 | ||
| Corneal Nerve Morphology, Sensitivity, and Tear Neuropeptides in Contact Lens Wear. | Q50212552 | ||
| Autotaxin-Lysophosphatidic Acid Pathway in Intraocular Pressure Regulation and Glaucoma Subtypes. | Q50215305 | ||
| Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients. | Q50279252 | ||
| Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. | Q50548182 | ||
| Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy. | Q50674112 | ||
| Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy | Q79138206 | ||
| Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy | Q80020556 | ||
| Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes | Q80725517 | ||
| Aqueous humor myocilin protein levels in normal, genetic carriers, and glaucoma Beagles | Q81150259 | ||
| Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes | Q81357274 | ||
| Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy | Q82717721 | ||
| Tear osmolarity in the diagnosis and management of dry eye disease | Q83395082 | ||
| Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis | Q84043469 | ||
| Evaluation of tear osmolarity in non-Sjögren and Sjögren syndrome dry eye patients with the TearLab system | Q84117967 | ||
| Tumor necrosis factor-alpha concentrations in the aqueous humor of patients with glaucoma | Q84528889 | ||
| Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays | Q84579952 | ||
| Immune response in the conjunctival epithelium of patients with dry eye | Q84589672 | ||
| Limitations of an ocular surface inflammatory biomarker in impression cytology specimens | Q84739059 | ||
| Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye | Q84866842 | ||
| Differential Profiling of T-Cell Cytokines as Measured by Protein Microarray Across Dry Eye Subgroups | Q87050411 | ||
| Serum and Vitreous Pentraxin 3 Concentrations in Patients with Diabetic Retinopathy | Q87210219 | ||
| Alteration of tear mucin 5AC in office workers using visual display terminals: The Osaka Study | Q88027597 | ||
| Evaluation of oxidative stress markers in aqueous humor of primary open angle glaucoma and primary angle closure glaucoma patients | Q88044433 | ||
| Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies | Q88073084 | ||
| Variability of Tear Osmolarity Measurements With a Point-of-Care System in Healthy Subjects-Systematic Review | Q88276926 | ||
| Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial | Q88716938 | ||
| Proteomic Analysis of Aqueous Humor from Primary Open Angle Glaucoma Patients on Drug Treatment Revealed Altered Complement Activation Cascade | Q89100912 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | conjunctiva | Q273554 |
| biomarker | Q864574 | ||
| eye disease | Q3041498 | ||
| pharmaceutical science | Q7180763 | ||
| molecular medicine | Q3523816 | ||
| biotechnology | Q7108 | ||
| Vitreous | Q57047809 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 40 | |
| P577 | publication date | 2019-01-23 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Review of Biomarkers in Ocular Matrices: Challenges and Opportunities | |
| P478 | volume | 36 |
| Q98611558 | Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker |
| Q92994541 | Endophthalmitis Management: Stain-Culture, Empirical Treatment, and Beyond |
| Q98288337 | Inflammatory and angiogenic biomarkers in diabetic retinopathy |
| Q92759529 | Proteome alterations in aqueous humour of primary open angle glaucoma patients |
| Q92372126 | Tear Metabolomics in Dry Eye Disease: A Review |
Search more.